Search

Your search keyword '"Cuerpo, Gregorio"' showing total 46 results
Start Over Author "Cuerpo, Gregorio"
46 results on '"Cuerpo, Gregorio"'

3. Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry.

Author

Caliskan, Etem, Misfeld, Martin, Sandner, Sigrid, Böning, Andreas, Aramendi, Jose, Salzberg, Sacha P., Yeong-Hoon Choi, Perrault, Louis P., Tekin, Ilker, Cuerpo, Gregorio P., Lopez-Menendez, Jose, Weltert, Luca P., Böhm, Johannes, Krane, Markus, González-Santos, José M., Tellez, Juan-Carlos, Holubec, Tomas, Ferrari, Enrico, Doros, Gheorghe, and Emmert, Maximilian Y.

Published
2024
Full Text
View/download PDF

9. Registro Español de Reparación Valvular 2015

Author

Lima-Cañadas, Pedro P., Sáez de Ibarra Sánchez, José Ignacio, Sanchez Dominguez, Eladio, Gutiérrez García, Francisco, Rodríguez-Roda Stuart, Jorge, Daroca Martinez, Tomas, García Fuster, Rafael, Vidal, Gomez, Carrascal Hinojal, Yolanda, González Santos, José María, Chuquiure, Javier, Castellà Pericas, Manuel, Rodríguez Lecoq, Rafael, Porras, Carlos, Aramendi, Ignacio, Iglesias Gil, Carmen, Sbraga, Fabrizio, Morales Pérez, Carlos A., Bernabeu, Eduardo, Llorens León, Rafael, Castaño Ruiz, Mario, Muñoz-Guijosa, Christian, Bel Mínguez, Ana M., Delgado Ramis, Luis, Cuerpo, Gregorio P., Adsuar Gómez, Alejandro, Cobiella, Javier, and Martín López, Carlos E.

Published
2017
Full Text
View/download PDF

10. Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry

Author

Ramos-Martínez, Antonio, Roque, Fernado, Fariñas, Maria Carmen, Muñoz, Patricia, Verde, Eduardo, Cuerpo, Gregorio Pablo, de Alarcón, Arístides, Lepe, José Antonio, Miró, José María, Plata, Antonio, Goenaga, Miguel Ángel, García-Rosado, Dácil, Martínez-Monzonis, Amparo, de la Torre, Javier, and García-Pavía, Pablo

Published
2017
Full Text
View/download PDF

13. Outcomes after surgical revascularization in diabetic patients.

Author

Misfeld, Martin, Sandner, Sigrid, Caliskan, Etem, Böning, Andreas, Aramendi, Jose, Salzberg, Sacha P, Choi, Yeong-Hoon, Perrault, Louis P, Tekin, Ilker, Cuerpo, Gregorio P, Lopez-Menendez, Jose, Weltert, Luca P, Adsuar-Gomez, Alejandro, Thielmann, Matthias, Serraino, Giuseppe F, Doros, Gheorghe, Borger, Michael A, Emmert, Maximilian Y, and investigators, European DuraGraft Registry

Published
2024
Full Text
View/download PDF

15. Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation

Author

Anguita-Gámez, María, primary, Giraldo, María A, additional, Nombela-Franco, Luis, additional, Eixeres Esteve, Andrea, additional, Cuerpo, Gregorio, additional, Lopez-Menendez, Jose, additional, Gomez-Polo, Juan Carlos, additional, Tirado-Conte, Gabriela, additional, Torres, Berenice, additional, Pedraz Prieto, Alvaro, additional, Jimenez-Quevedo, Pilar, additional, Lopez-Gude, María Jesus, additional, Mahia, Patricia, additional, Cobiella, Javier, additional, Zamorano, José Luis, additional, Vilacosta, Isidre, additional, Maroto, Luis, additional, and Carnero-Alcázar, Manuel, additional

Published
2023
Full Text
View/download PDF

16. Posicionamiento de la Sociedad Española de Cirugía Cardiovascular y Endovascular (SECCE) con relación al número de servicios de cirugía cardiovascular en España

Author

Rodríguez-Roda, Jorge, primary, José Legarra, Juan, additional, Carnero, Manuel, additional, Emilio Monguió, Manuel, additional, Pablo Cuerpo, Gregorio, additional, García Fuster, Rafael, additional, López Menéndez, José, additional, Martín, Elio, additional, Ortiz, Daniel, additional, Manuel Martínez Comendador, José, additional, Rubio, Lorena, additional, Francisco Valderrama, José, additional, and Blasco, Arnau, additional

Published
2023
Full Text
View/download PDF

20. Atrial myxoma surgery and P‐wave remodeling

Author

Herrera, Cristian, primary, Bruña, Vanesa, additional, Barrio, Jose María, additional, Cuerpo, Gregorio, additional, Fernández‐Avilés, Francisco, additional, Bayés de Luna, Antonio, additional, and Martínez‐Sellés, Manuel, additional

Published
2022
Full Text
View/download PDF

21. Should Advanced Friedreich’s Ataxia Be a Contraindication for Heart Transplantation? A Case Report of a Successful Procedure in a 58-Year-Old Patient

Author

Valero Masa, María Jesús, Muñoz Blanco, Jose L., Garrido Sánchez, Alejandro, Cuerpo, Gregorio, Castrodeza, Javier, Navarro López, Paula, Sousa Casasnovas, Iago, Villa Arranz, Adolfo, Fernández Avilés, Francisco, Martínez-Sellés d'Oliveira Soares, Manuel, Valero Masa, María Jesús, Muñoz Blanco, Jose L., Garrido Sánchez, Alejandro, Cuerpo, Gregorio, Castrodeza, Javier, Navarro López, Paula, Sousa Casasnovas, Iago, Villa Arranz, Adolfo, Fernández Avilés, Francisco, and Martínez-Sellés d'Oliveira Soares, Manuel

Abstract

The information on heart transplantation (HT) in patients with Friedreich’s Ataxia (FA) is scarce, and the few published case reports are limited to young patients with mild neurological manifestations. We present the case of a 58-year-old patient with advanced FA (Scale for the Assessment and Rating of Ataxia [SARA] score 30/40), wheelchair-bound for the last 16 years and had urinary incontinence, dysarthria, and neurosensorial deafness. The patient was admitted for a refractory arrhythmic storm and had previous hypertrophic cardiomyopathy that evolved to dilated cardiomyopathy with severely reduced left ventricular ejection fraction and recurrent ventricular arrhythmias. A multidisciplinary team discussed the HT option. The patient was aware of the risks and benefits and considered worthy of the intervention, so he was listed for HT. After a successful surgical intervention, the patient had a long postoperative stay in ICU. He required a high dose of vasopressors, underwent hemofiltration for one month, suffered critical illness myopathy, had several respiratory infections and delayed tracheal extubation. Two and a half months after HT and almost five months at the hospital, the patient was successfully discharged. FA patients with severe heart conditions should be carefully evaluated by a multidisciplinary team to decide the candidacy for HT., Depto. de Medicina, Fac. de Medicina, TRUE, pub

Published
2022

22. Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study.

Author

Sandner, Sigrid, Misfeld, Martin, Caliskan, Etem, Böning, Andreas, Aramendi, Jose, Salzberg, Sacha P., Yeong-Hoon Choi, Perrault, Louis P., Tekin, Ilker, Cuerpo, Gregorio P., Lopez-Menendez, Jose, Weltert, Luca P., Böhm, Johannes, Krane, Markus, González-Santos, José M., Tellez, Juan-Carlos, Holubec, Tomas, Ferrari, Enrico, Doros, Gheorghe, and Vitarello, Clara J.

Abstract

Objectives: The objective of the European Multicenter Registry to Assess Outcomes in coronary artery bypass grafting (CABG) patients (DuraGraft Registry) was to determine clinical outcomes and quality of life (QoL) after contemporary CABG that included isolated CABG and combined CABG/valve procedures, using an endothelial damage inhibitor (DuraGraft) intraoperatively for conduit preservation. Here, we report outcomes in the patient cohort undergoing isolated CABG. Methods: The primary outcome was the composite of all-cause death, myocardial infarction (MI), or repeat revascularization (RR) [major adverse cardiac events (MACE)] at 1 year. Secondary outcomes included the composite of all-cause death, MI, RR, or stroke [major adverse cardiac and cerebrovascular events (MACCE)], and QoL. QoL was assessed with the EuroQol-5 Dimension questionnaire. Independent risk factors for MACE at 1 year were determined using Cox regression analysis. Results: A total of 2532 patients (mean age, 67.4 ± 9.2 years; 82.5% male) underwent isolated CABG. The median EuroScore II was 1.4 [interquartile range (IQR), 0.9-2.3]. MACE and MACCE rates at 1 year were 6.6% and 7.8%, respectively. The rates of allcause death, MI, RR, and stroke were 4.4, 2.0, 2.2, and 1.9%, respectively. The 30-day mortality rate was 2.3%. Age, extracardiac arteriopathy, left ventricular ejection fraction less than 50%, critical operative state, and left main disease were independent risk factors for MACE. QoL index values improved from 0.84 [IQR, 0.72-0.92] at baseline to 0.92 [IQR, 0.82-1.00] at 1 year (P <0.0001). Conclusion: Contemporary European patients undergoing isolated CABG have a low 1-year clinical event rate and an improved QoL. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

23. Should Advanced Friedreich’s Ataxia Be a Contraindication for Heart Transplantation? A Case Report of a Successful Procedure in a 58-Year-Old Patient

Author

Valero, María Jesús, primary, Muñoz-Blanco, Jose L., additional, Sanchez, Alejandro Garrido, additional, Cuerpo, Gregorio, additional, Castrodeza, Javier, additional, Navas, Paula, additional, Sousa, Iago, additional, Villa, Adolfo, additional, Fernández-Avilés, Francisco, additional, and Martínez-Sellés, Manuel, additional

Published
2022
Full Text
View/download PDF

26. Clinical event rate in patients with and without left main disease undergoing isolated coronary artery bypass grafting: results from the European DuraGraft Registry.

Author

Caliskan, Etem, Misfeld, Martin, Sandner, Sigrid, Böning, Andreas, Aramendi, Jose, Salzberg, Sacha P, Choi, Yeong-Hoon, Perrault, Louis P, Tekin, Ilker, Cuerpo, Gregorio P, Lopez-Menendez, Jose, Weltert, Luca P, Böhm, Johannes, Krane, Markus, González-Santos, José M, Tellez, Juan-Carlos, Holubec, Tomas, Ferrari, Enrico, Emmert, Maximilian Y, and investigators, European DuraGraft Registry

Subjects
CORONARY artery bypass, MYOCARDIAL infarction, MAJOR adverse cardiovascular events, PROPENSITY score matching, CORONARY artery disease
Abstract

Open in new tab Download slide OBJECTIVES Left main coronary artery disease (LMCAD) is considered an independent risk factor for clinical events after coronary artery bypass grafting (CABG). We have conducted a subgroup analysis of the multicentre European DuraGraft Registry to investigate clinical event rates at 1 year in patients with and without LMCAD undergoing isolated CABG in contemporary practice. METHODS Patients undergoing isolated CABG were selected. The primary end point was the incidence of a major adverse cardiac event (MACE) defined as the composite of death, myocardial infarction (MI) or repeat revascularization (RR) at 1 year. The secondary end point was major adverse cardiac and cerebrovascular events (MACCE) defined as MACE plus stroke. Propensity score matching was performed to balance for differences in baseline characteristics. RESULTS LMCAD was present in 1033 (41.2%) and absent in 1477 (58.8%) patients. At 1 year, the MACE rate was higher for LMCAD patients (8.2% vs 5.1%, P  = 0.002) driven by higher rates of death (5.4% vs 3.4%, P  = 0.016), MI (3.0% vs 1.3%, P  = 0.002) and numerically higher rates of RR (2.8% vs 1.8%, P  = 0.13). The incidence of MACCE was 8.8% vs 6.6%, P  = 0.043, with a stroke rate of 1.0% and 2.4%, P  = 0.011, for the LMCAD and non-LMCAD groups, respectively. After propensity score matching, the MACE rate was 8.0% vs 5.2%, P  = 0.015. The incidence of death was 5.1% vs 3.7%, P  = 0.10, MI 3.0% vs 1.4%, P  = 0.020, and RR was 2.7% vs 1.6%, P  = 0.090, for the LMCAD and non-LMCAD groups, respectively. Less strokes occurred in LMCAD patients (1.0% vs 2.4%, P  = 0.017). The MACCE rate was not different, 8.5% vs 6.7%, P  = 0.12. CONCLUSIONS In this large registry, LMCAD was demonstrated to be an independent risk factor for MACE after isolated CABG. Conversely, the risk of stroke was lower in LMCAD patients. Clinical trial registration number ClinicalTrials.gov NCT02922088. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

27. Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry

Author

Cuerpo, Gregorio P, Valerio, M, Pedraz, A, Rodríguez-Abella, H, Mestres, Carlos A, Obrador, Eduardo Quintana, González-Calle, Antonio, Rodríguez Álvarez, Regino, García, Patricia Muñoz, Bouza, Emilio, GAMEs Study Group, University of Zurich, and Cuerpo, Gregorio P

Subjects
2740 Pulmonary and Respiratory Medicine, 610 Medicine & health, Cardiac surgery Infectious endocarditis Mitral valve Reparation Mitral valve replacement, 2705 Cardiology and Cardiovascular Medicine, 10020 Clinic for Cardiac Surgery, 2746 Surgery
Published
2019

28. Disseminated lomentosporiosis in a heart transplant recipient: Case report and review of the literature

Author

Valerio, Maricela, primary, Vásquez, Víctor, additional, Álvarez‐Uria, Ana, additional, Zatarain‐Nicolás, Eduardo, additional, Pavone, Paolo, additional, Martínez‐Jiménez, María del Carmen, additional, Barrio‐Gutiérrez, José María, additional, Cuerpo, Gregorio, additional, Guinea‐Ortega, Jesús, additional, Vena, Antonio, additional, Peligros‐Gómez, María Isabel, additional, Bouza, Emilio, additional, and Muñoz, Patricia, additional

Published
2021
Full Text
View/download PDF

30. Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study

Author

Rivoisy, Claire, Vena, Antonio, Schaeffer, Laura, Charlier, Caroline, Fontanet, Arnaud, Delahaye, François, Bouza, Emilio, Lortholary, Olivier, Lefort, Agnès, Yazdanpanah, Yazdan, Wolff, Michel, Houze, Sandrine, Ferry, Tristan, Wallon, Martine, Strady, Christophe, Toubas, Dominique, Bréchot, Nicolas, Henry, Benoit, Fekkar, Arnaud, Fourme, Thierry, Amouroux, Isabelle, Mainardi, Jean-Luc, Dannaoui, Eric, Rogeaux, Olivier, Levast, Marion, Chirouze, Catherine, Million, Laurence, Bastides, Frédéric, Chandenier, Jacques, Lançon, Jean-Pierre, Ovize, Anne, Abgueguen, Pierre, Bouchara, Jean-Philippe, Tric, Laurent, Habib, Gilbert, Gourriet, Frederic, Aaron, Laurent, Bougnoux, Marie Elisabeth, Camou, Fabrice, Accoceberry, Isabelle, Sánchez, Fernando Fernández, Noureddine, Mariam, Rosas, Gabriel, de la Torre Lima, Javier, Aramendi, José, Bereciartua, Elena, Victoria Boado, María, Campaña Lázaro, Marta, Goikoetxea, Josune, José Goiti, Juan, Hernández, José Luis, Iruretagoyena, José Ramón, Zuazabal, Josu Irurzun, López-Soria, Leire, Montejo, Miguel, Pérez, Pedro María, Rodríguez, Regino, Voces, Roberto, López, Mª Victoria García, Georgieva, Radka Ivanova, Solero, Manuel Márquez, Bailón, Isabel Rodríguez, Morales, Josefa Ruiz, Cuende, Ana María, Echeverría, Tomás, Fuerte, Ana, Gaminde, Eduardo, Goenaga, Miguel Ángel, Idígoras, Pedro, Iribarren, José Antonio, Yarza, Alberto Izaguirre, Urkola, Xabier Kortajarena, Reviejo, Carlos, Carrasco, Rafael, Climent, Vicente, Llamas, Patricio, Merino, Esperanza, Plazas, Joaquín, Reus, Sergio, Álvarez, Nemesio, Bravo-Ferrer, Jose María, Castelo, Laura, Cuenca, José, Llinares, Pedro, Rey, Enrique Miguez, Mayo, María Rodríguez, Sánchez, Efrén, Regueiro, Dolores Sousa, Martinez, Francisco Javier, del Mar Alonso, Mª, Castro, Beatriz, Marrero, Dácil García, Durán, Mª del Carmen, Gómez, Mª Antonia Miguel, Calzada, Juan La, Nassar, Ibrahim, Ciezar, Antonio Plata, Iglesias, José Mª Reguera, Asensio, Víctor, Costas, Carlos, de la Hera, Jesús, Suárez, Jonnathan Fernández, Fraile, Lisardo Iglesias, Arguero, Víctor León, Menéndez, José López, MenciaBajo, Pilar, Morales, Carlos, Torrico, Alfonso Moreno, Palomo, Carmen, Martínez, Begoña Paya, Esteban, Ángeles Rodríguez, García, Raquel Rodríguez, Asensio, Mauricio Telenti, Almela, Manuel, Armero, Yolanda, Azqueta, Manuel, Brunet, Merce, Cartañá, Ramón, Cervera, Carlos, Falces, Carlos, Fita, Guillermina, Fuster, David, de la Maria, Cristina García, Gatell, José, Pérez, Jaume Llopis, Marco, Francesc, Mestres, Carlos, Miró, José Mª, Moreno, Asunción, Ninot, Salvador, Quintana, Eduardo, Paré, Carlos, Pericás, Juan Manuel, Pomar, José, Ramírez, José, Rovira, Irene, Sitges, Marta, Soy, Dolors, Téllez, Adrián, Vila, Jordi, Bermejo, Javier, Cuerpo, Gregorio, de Egea, Viviana, Eworo, Alia, Cruz, Ana Fernández, Leoni, Mª Eugenia García, del Vecchio, Marcela González, Ramallo, Víctor González, Hernández, Martha Kestler, Marín, Mercedes, Martínez-Sellés, Manuel, Menárguez, Mª Cruz, Muñoz, Patricia, Rincón, Cristina, Rodríguez-Abella, Hugo, Rodríguez-Créixems, Marta, Pinilla, Blanca, Pinto, Ángel, Valerio, Maricela, Moreno, Eduardo Verde, Antorrena, Isabel, Loeches, Belén, Moreno, Mar, Ramírez, Ulises, Bastón, Verónica Rial, Romero, María, Saldaña, Araceli, Castillo, Carlos Armiñanzas, Arnaiz, Ana, Berrazueta, José, Bellisco, Sara, Belaustegui, Manuel Cobo, Durán, Raquel, Fariñas, MªCarmen, Fariñas-Álvarez, Concepción, Mazarrasa, Carlos Fernández, Izquierdo, Rubén Gómez, Rico, Claudia González, Díez, José Gutiérrez, Durán, Rafael Martín, Pajarón, Marcos, Parra, José Antonio, Teira, Ramón, Zarauza, Jesús, Pavía, Pablo García, González, Jesús, Orden, Beatriz, RAMOS, Antonio, González, Elena Rodríguez, Centella, Tomasa, Hermida, José Manuel, Luis Moya, José, Martín-Dávila, Pilar, Navas, Enrique, Oliva, Enrique, del Río, Alejandro, Ruiz, Soledad, Tenorio, Carmen Hidalgo, de Castro, Antonio, de Cueto, Marina, Gallego, Pastora, Acebal, Juan Gálvez, Baño, Jesús Rodríguez, de Alarcón, Arístides, García, Emilio, Haro, Juan Luis, Lepe, José Antonio, López, Francisco, Luque, Rafael, Alonso, Luis Javier, Gutiérrez, José Manuel Azcona, Blanco, José Ramón, García, Lara, Oteo, José Antonio, de Benito, Natividad, Gurguí, Mercé, Pacho, Cristina, Pericas, Roser, Pons, Guillem, Alvarez, M., Fernández, A, Prieto, A., Regueiro, Benito, Tijeira, E, Vega, Marino, Blasco, Andrés Canut, Mollar, José Cordo, Arana, Juan Carlos Gainzarain, Uriarte, Oscar García, López, Alejandro Martín, de Zárate, Zuriñe Ortiz, Matos, José Antonio Urturi, Nacle, Mª Belén, Sánchez-Porto, Antonio, Vallejo, Luis, ArribasLeal, José Mª, Vázquez, Elisa García, Torres, Alicia Hernández, Blázquez, Ana, de la Morena Valenzuela, Gonzalo, Alonso, Ángel, Aramburu, Javier, Calvo, Felicitas Elena, Rodríguez, Anai Moreno, Tarabini-Castellani, Paola, Gálvez, Eva Heredero, Bellido, Carolina Maicas, Pau, José Largo, Sepúlveda, Mª Antonia, Sierra, Pilar Toledano, Iqbal-Mirza, Sadaf Zafar, Alcolea, Eva Cascales, Serrano, Pilar Egea, Hernández Roca, José Joaquín, Service des Maladies infectieuses et tropicales [CHU Necker], Université Paris Descartes - Paris 5 (UPD5)-CHU Necker - Enfants Malades [AP-HP]-Institut des Maladies Génétiques Imagine [Paris], Hospital General Universitario 'Gregorio Marañón' [Madrid], Epidémiologie des Maladies Emergentes, Pasteur-Cnam risques infectieux et émergents (PACRI), Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Centre d'infectiologie Necker-Pasteur [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Mère et enfant face aux infections tropicales (MERIT - UMR_D 216), Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5), Service de Parasitologie, Hospices Civils de Lyon (HCL)-Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Matrice extracellulaire et dynamique cellulaire - UMR 7369 (MEDyC), SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Centre National de la Recherche Scientifique (CNRS), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP], Institut Élie Cartan de Lorraine (IECL), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [APHP], Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Mycologie moléculaire, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Service des Maladies Infectieuses, CHR Chambéry, Laboratoire de Bactériologie, Centre Hospitalier Régional de Chambéry, Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Service de Médecine Interne et Maladies Infectieuses [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), CHU Tours, Service de Parasitologie - Mycologie - Médecine Tropicale, Eurofins Biomnis [Lyon, France], Service des maladies infectieuses et tropicales [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Groupe d’Etude des Interactions Hôte-Pathogène, Université d'Angers (UA), Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Biologie et Pathogénicité fongiques, Institut National de la Recherche Agronomique (INRA)-Institut Pasteur [Paris], Hôpital St-André, Réanimation, CHU Bordeaux [Bordeaux], Microbiologie cellulaire et moléculaire et pathogénicité (MCMP), Université Bordeaux Segalen - Bordeaux 2-Centre National de la Recherche Scientifique (CNRS), Universitad Politecnica de Alicante (UPA), Departamento de Lenguajes y Sistemas Informaticos, Instituto Tecnologico de Aragon (ITA), Instituto Tecnológico de Aragón, Department of Anatomy and Cell Biology [Montréal], McGill University, Universitat de Barcelona (UB), AIDS Research Group [Barcelona, Spain], August Pi i Sunyer Biomedical Research Institute - IDIBAPS [Barcelona, Spain]-Hospital Clinic [Barcelona, Spain], Instituto Tecnológico de Tláhuac, Cardiology Department, Thorax Clinic Institute, Hospital Cliınic, Institut d'Investigacions Biomèdiques [Barcelona], Clinical Microbiology and Infectious Diseases Department, Universidad Complutense de Madrid [Madrid] (UCM), Universidade de Aveiro, Departamento de Quimica Organica [Universidad de Cordoba], Universidad de Córdoba [Cordoba], Department of Microbiology, Hospital de la Santa Creu i Sant Pau, University Rovirai Virgili de Tarragona (URV), Chercheur indépendant, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Mère et enfant en milieu tropical : pathogènes, système de santé et transition épidémiologique (MERIT - UMR_D 216), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA)-Centre National de la Recherche Scientifique (CNRS), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Laboratoire Chrono-environnement (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Eurofins Biomnis, Groupe d'Étude des Interactions Hôte-Pathogène (GEIHP), Biologie et Pathogénicité fongiques (BPF), Institut National de la Recherche Agronomique (INRA)-Institut Pasteur [Paris] (IP), Microbiologie Fondamentale et Pathogénicité (MFP), Instituto Tecnológico de Aragón (ITAINNOVA), McGill University = Université McGill [Montréal, Canada], Universidad de Córdoba = University of Córdoba [Córdoba], This work was supported by the Programa Multidisciplinar para la Gestión de Antifúngicos y la Reducción de Candidiasis Invasora (PROMULGA) II Project, Instituto de Salud Carlos III, partially financed by the European Regional Development Fund (grant PI13/01148). A. V. is supported by a Rio Hortega contract from the Instituto de Salud Carlos III, also partially financed by the European Regional Development Fund (grant CM15/00181)., Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Beaujon-Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Institut Pasteur [Paris]-Institut National de la Recherche Agronomique (INRA), Hospital Clinic [Barcelona, Spain]-August Pi i Sunyer Biomedical Research Institute - IDIBAPS [Barcelona, Spain], and Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Male, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Antifungal Agents, Prosthesis-Related Infections, Echinocandin, 030106 microbiology, 03 medical and health sciences, Candida, endocarditis, prosthetic valve, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Amphotericin B, Internal medicine, Humans, Medicine, Endocarditis, Prospective Studies, Registries, Adverse effect, Prospective cohort study, Fluconazole, Survival rate, ComputingMilieux_MISCELLANEOUS, [SDV.MP.MYC]Life Sciences [q-bio]/Microbiology and Parasitology/Mycology, Aged, Retrospective Studies, business.industry, Candidiasis, Disease Management, Retrospective cohort study, Odds ratio, Middle Aged, Prognosis, medicine.disease, 3. Good health, Infectious Diseases, Spain, Heart Valve Prosthesis, Female, France, business, medicine.drug
Abstract

International audience; Background: Prosthetic valve endocarditis caused by Candida spp. (PVE-C) is rare and devastating, with international guidelines based on expert recommendations supporting the combination of surgery and subsequent azole treatment.Methods: We retrospectively analyzed PVE-C cases collected in Spain and France between 2001 and 2015, with a focus on management and outcome.Results: Forty-six cases were followed up for a median of 9 months. Twenty-two patients (48%) had a history of endocarditis, 30 cases (65%) were nosocomial or healthcare related, and 9 (20%) patients were intravenous drug users. "Induction" therapy consisted mainly of liposomal amphotericin B (L-amB)-based (n = 21) or echinocandin-based therapy (n = 13). Overall, 19 patients (41%) were operated on. Patients

Published
2018
Full Text
View/download PDF

31. Pulmonary Infective Endocarditis

Author

Prieto-Arévalo, Raquel, primary, Muñoz, Patricia, additional, Cuerpo, Gregorio, additional, Marí-Hualde, Amaia, additional, Castelo-Corral, Laura, additional, Navas-Elorza, Enrique, additional, Cifuentes-Luna, Carmen, additional, Alonso-Socas, Maria del Mar, additional, Boix-Palop, Lucía, additional, and Martínez-Sellés, Manuel, additional

Published
2019
Full Text
View/download PDF

32. 2015 Spanish Valve Repair Registry

Author

Lima-Canadas, Pedro P., de Ibarra Sanchez, Jose Ignacio Saez, Sanchez Dominguez, Eladio, Gutierrez Garcia, Francisco, Rodriguez-Roda Stuart, Jorge, Daroca Martinez, Tomas, Garcia Fuster, Rafael, Vidal, Gomez, Carrascal Hinojal, Yolanda, Gonzalez Santos, Jose Maria, Chuquiure, Javier, Castella Pericas, Manuel, Rodriguez Lecoq, Rafael, Porras, Carlos, Aramendi, Ignacio, Iglesias Gil, Carmen, Sbraga, Fabrizio, Morales Perez, Carlos A., Bernabeu, Eduardo, Llorens Leon, Rafael, Castano Ruiz, Mario, Munoz-Guijosa, Christian, Bel Minguez, Ana M., Delgado Ramis, Luis, Cuerpo, Gregorio P., Adsuar Gomez, Alejandro, Cobiella, Javier, and Martin Lopez, Carlos E.

Subjects
Database, Registry, cardiovascular system, Mitral valve, cardiovascular diseases, Valve repair, Valve replacement
Abstract

Introduction and objectives: The Working Group on Valve Repair of the Spanish Society of Thoracic and Cardiovascular Surgery presents the fifth annual report on reconstructive valve surgery of the mitral, aortic and tricuspid valves performed in Spain during 2015. Material and methods: The data was gathered using an online form, in a retrospective, voluntary, anonymous and non-audited way. Different parameters regarding etiology, type of surgery, mortality and risk scores were collected, both in the whole group and in the elective group. Results: Data was collected from 31 centers with 9112 interventions. Mitral repair surgery accounts for 29,2% of all mitral valve operated, with a major different both in risk profile and in etiology. The ratio between repair and replacement for aortic valve has a rising trend with an important variability between surgical groups. Tricuspid surgery is mainly conservative with a wide use of prosthetic rings, and a stable number of replacements. Conclusions: Mitral valve repair is a established option in our country, being highly dependent on etiology. There is a trend towards an increase in repair/replacement ratio and tricuspid valve repair is stable.

Published
2017

34. Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis

Author

Angulo-Llanos, Rocío, primary, Sarnago-Cebada, Fernando, additional, Rivera, Allan R., additional, Elízaga Corrales, Jaime, additional, Cuerpo, Gregorio, additional, Solis, Jorge, additional, Gutierrez-Ibañes, Enrique, additional, Sanz-Ruiz, Ricardo, additional, Vázquez Álvarez, ME, additional, and Fernandez-Avilés, Francisco, additional

Published
2016
Full Text
View/download PDF

43. NT-proBNP in cardiac surgery: a new tool for the management of our patients?

Author

Reyes, Guillermo, Forés, Gloria, Rodríguez-Abella, R Hugo, Cuerpo, Gregorio, Vallejo, José Luis, Romero, Carlos, and Pinto, Angel

Abstract

Our aim was to determine NT-proBNP levels in patients undergoing cardiac surgery and if those levels are related to any of the baseline clinical characteristics of patients before surgery or any of the outcomes or events after surgery.

Published
2005
Full Text
View/download PDF

44. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe

Author

Hortal, Javier, Munoz, Patricia, Cuerpo, Gregorio, Litvan, Hector, Rosseel, Peter M., Bouza, Emilio, European Study Grp Nosocomial Infe, and European Workgrp Cardiothoracic In

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, humanos, Critical Care and Intensive Care Medicine, incidencia, law.invention, Risk Factors, law, estudios prospectivos, medicine, factores de riesgo, Humans, análisis multifactorial, Prospective Studies, Cardiac Surgical Procedures, Antibiotic prophylaxis, procedimientos quirúrgicos cardíacos, Prospective cohort study, mediana edad, Mechanical ventilation, business.industry, resultado del tratamiento, Incidence, Research, Incidence (epidemiology), profilaxis antibiótica, Ventilator-associated pneumonia, Pneumonia, Ventilator-Associated, neumonía, Pneumonia, Odds ratio, Antibiotic Prophylaxis, Middle Aged, medicine.disease, Intensive care unit, Surgery, Europe, Treatment Outcome, Multivariate Analysis, Female, business
Abstract

Introduction Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our aim was to determine the incidence, aetiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients who have undergone MHS in Europe. Methods Our study was a prospective study of patients undergoing MHS in Europe who developed suspicion of VAP. During a one-month period, participating units submitted a protocol of all patients admitted to their units who had undergone MHS. Results Overall, 25 hospitals in eight different European countries participated in the study. The number of patients intervened for MHS was 986. Fifteen patients were excluded because of protocol violations. One or more nosocomial infections were detected in 43 (4.4%) patients. VAP was the most frequent nosocomial infection (2.1%; 13.9 episodes per 1000 days of mechanical ventilation). The microorganisms responsible for VAP in this study were: Enterobacteriaceae (45%), Pseudomonas aeruginosa (20%), methicillin-resistant Staphylococcus aureus (10%) and a range of other microorganisms. We identified the following significant independent risk factors for VAP: ascending aorta surgery (odds ratio (OR) = 6.22; 95% confidence interval (CI) = 1.69 to 22.89), number of blood units transfused (OR = 1.08 per unit transfused; 95% CI = 1.04 to 1.13) and need for re-intervention (OR = 6.65; 95% CI = 2.10 to 21.01). The median length of stay in the intensive care unit was significantly longer (P < 0.001) in patients with VAP than in patients without VAP (23 days versus 2 days). Death was significantly more frequent (P < 0.001) in patients with VAP (35% versus 2.3%). Conclusions Patients undergoing aortic surgery and those with complicated post-intervention courses, requiring multiple transfusions or re-intervention, constitute a high-risk group probably requiring more active preventive measures., The study was supported in part by Ciber de Enfermedades Respiratorias (CIBERES) and by the Rafael del Pino Foundation. We thank Lawrence JC Baron for his review of the English version of the manuscript and Cristina Fernandez for her contribution to the statistical analysis. We thank Dr M Desco and Dr J Pascau of the Medical Image Laboratory of Experimental Medicine for their support with the electronic retrieval of the data.

Full Text
View/download PDF

45. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe

Author

Hortal, Javier, Muñoz, Patricia, Cuerpo, Gregorio, Litvan, Hector, Rosseel, Peter, and Bouza, Emilio

Abstract

Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our aim was to determine the incidence, aetiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients who have undergone MHS in Europe.

Published
2009
Full Text
View/download PDF

46. Infections in patients after Berlin Heart ® EXCOR assist device implantation.

Author

Muñoz P, Valerio M, Vásquez V, Velásquez-Rodríguez J, Sousa I, Zatarain E, Barrio JM, Ruiz M, Cuerpo G, Rodríguez-Abella H, Hortal J, and Bouza E

Subjects
Adult, Aged, Communicable Diseases etiology, Communicable Diseases microbiology, Female, Follow-Up Studies, Humans, Male, Middle Aged, Spain epidemiology, Communicable Diseases epidemiology, Heart Failure surgery, Heart Transplantation adverse effects, Heart-Assist Devices adverse effects
Abstract

Objectives: Berlin Heart ® EXCOR devices (BHED) are ventricular assist devices (VAD) used mainly as a bridge to heart transplantation (HT) in pediatric population. The aim of our study is to report the infections diagnosed in adult patients undergoing a BHED implantation., Methods: Adult patients receiving a BHED between Jul 2009 and Oct 2017 at our institution were included. Infections were classified according to the International Society of Heart and Lung Transplantation definitions in VAD-Specific (VAD-S), VAD-Related (VAD-R) and non-VAD (N-VAD)., Results: Fifteen patients underwent BHED implantation, which was maintained for a mean of 92 (19-195) days. Infection occurred in 13 patients who developed 36 infectious episodes: 5 VAD-S (5 cannula infections); 8 VAD-R (5 bloodstream infections and 3 mediastinitis) and 24 N-VAD (7 urinary tract infections, 6 Cytomegalovirus diseases and others). Overall, 27 (75%) were bacterial, 7 (19.4%) were viral and there was one (2.7%) fungal infection. Eleven patients underwent HT and all of them developed at least one infection after it. In 3 cases, all VAD-R or VAD-S infections were caused by the same etiology as before HT. Their median time of appearance was on day +6 (3-11) after BHED removal and HT. Overall mortality was 6/15 (40%). None of the deaths were related to VAD Infection., Conclusions: Infection complicated BHED implantation in 86.7% of the patients. Overall, 13.9% were specific of BHED and 22.2% were related. However, infections did not preclude HT in any case and carried no attributable mortality., (© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results